Open-Label, Three Way, Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 Oral Solution Under Fasting Conditions vs Comparator Under Fed Conditions and to Determine Food Effect of DFN-15 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2018
At a glance
- Drugs Celecoxib (Primary) ; Celecoxib
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors Dr Reddys Laboratories
- 10 Feb 2018 Status changed from active, no longer recruiting to completed.
- 18 Sep 2017 Planned End Date changed from 14 Sep 2017 to 30 Oct 2017.
- 18 Sep 2017 New trial record